The first national guidelines for the prevention and control of C. difficile-associated disease were published in Ireland by the HSE-Health Protection Surveillance Centre (HPSC) in May 2008. Since publication, there has been significant developments in the diagnosis, prevention and treatment of C. difficile infection (CDI). The 2008 guidelines have been recently updated and were approved by the Scientific Advisory Committee of the HPSC in February 2013. The updated guidelines are currently being reviewed by the National Clinical Effectiveness Committee, Department of Health.
The updated guidelines are divided into four sections:
- Section A: Background (which includes an overview of CDI epidemiology in Ireland, summary of the financial and clinical impact of CDI, aims & scope and methodology for guideline review & an overview of potential barriers to implementation)
- Section B: Recommendations in a question and answer format
- Section C: Rationale for recommendations
- Section D: Appendices and references.
We plan to publish the updated guidelines in a more user friendly format in the coming months. In the meantime the full guidelines and a summary of the recommendations are available here.
Surveillance, Diagnosis and Management of Clostridium difficile Infection in Ireland Update of 2008 Guidance
Surveillance, Diagnosis and Management of Clostridium difficile Infection in Ireland Update of 2008 Guidance: Summary of Recommendations
- World AIDS Day 2013
28 November 2013
- European HIV Testing Week 22-29 November 2013
26 November 2013
- ESPID 2014
22 November 2013
- Module on Infection Prevention and Control in Healthcare, University of Limerick
22 November 2013